epirubicinol

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1985-2014
012319852014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Most adjuvant breast cancer treatment regimens include the combination of an anthracycline (epirubicin or doxorubicin) and the… (More)
  • table 2
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
2007
2007
The antitumor anthracycline doxorubicin induces a dose-related cardiotoxicity that correlates with the myocardial levels of its… (More)
Is this relevant?
2003
2003
We present a high-performance liquid chromatography (HPLC) method suitable for the analysis of epirubicin and its metabolite… (More)
Is this relevant?
2002
2002
BACKGROUND The objectives of this study were to investigate the disposition of gemcitabine, epirubicin, paclitaxel, 2',2… (More)
Is this relevant?
1997
1997
PURPOSE To determine the maximum-tolerated dose (MTD) of paclitaxel over 3 hours with a fixed dose of epirubicin, to investigate… (More)
Is this relevant?
1991
1991
Detailed pharmacokinetic analysis and subsequent evaluation of myelotoxicity were performed in 55 patients who had been… (More)
  • figure 1
  • table 1
  • table 2
  • figure 4
  • figure 2
Is this relevant?
1991
1991
Pharmacokinetic analysis of epirubicin and its metabolites epirubicinol and 7-deoxy-13-dihydro-epirubicinol aglycone during the… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
1989
1989
We have studied the growth inhibition, DNA synthesis inhibition and cell incorporation of five 13-dihydrometabolites of… (More)
Is this relevant?
1988
1988
The pharmacokinetics and metabolism of doxorubicin (DX) and epirubicin (epiDX) were investigated in eight cancer patients who… (More)
Is this relevant?
1985
1985
We have studied the metabolism and pharmacokinetics of epirubicin (4'-epidoxorubicin), as compared to those of doxorubicin, in a… (More)
Is this relevant?